Abstract
Expediency was studied of use of the drug terginan in a combined treatment of uterine neck pathologies in patients presenting with local inflammatory processes. The drug was found to be capable of dispelling an unspecific inflammatory process, normalizing the vaginal microbe landscape, promoting the postcryodestruction epithelization processes as evidenced by the analysis of the results obtained.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / therapeutic use*
-
Bacterial Infections / drug therapy*
-
Bacterial Infections / microbiology
-
Drug Combinations
-
Female
-
Humans
-
Inflammation / drug therapy*
-
Inflammation / microbiology
-
Male
-
Neomycin / therapeutic use
-
Nystatin / therapeutic use
-
Prednisolone / therapeutic use
-
Uterine Cervical Diseases / drug therapy*
-
Uterine Cervical Diseases / microbiology
-
Uterine Cervical Diseases / surgery
Substances
-
Anti-Inflammatory Agents
-
Drug Combinations
-
Nystatin
-
Prednisolone
-
Neomycin